You are here

Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects

Last updated on November 13, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Farmington, Connecticut, 06030-5215 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Frail Elderly
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
75 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Elderly subjects with moderate frailty residing in assisted living facilities.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Presence of progressive, unstable chronic disease; hyperparathyroidism, hypercalcemia.

NCT00249704
Pfizer
Terminated
Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Descriptive Information
Brief Title  ICMJE Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects
Official Title  ICMJE Evaluation of the Effect of a 4-Month Intervention of Exercise and/or Vitamin D on Mobility Function and Strength in Frail Elderly Subjects
Brief SummaryThe study will explore multiple mobility function tests as well as functional and neuropsychological tests in elderly subjects at risk for falls and disability, before and after 4-month exercise and/or Vitamin D intervention.
Detailed DescriptionThe study was terminated on 10Jan2008. This was a strategic decision not related to safety, efficacy, or feasibility of trial.
Study Type  ICMJE Interventional
Study Phase  ICMJE Phase 1
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Condition  ICMJE Elderly, Frail
Intervention  ICMJE
  • Drug: Vitamin D + Sham Exercise
    1000 IU per day of Vitamin D + Sham (equivalent to placebo) Exercise
  • Procedure: Vitamin D Placebo + Exercise
    Vitamin D placebo + Exercise
  • Procedure: Vitamin D Placebo + Sham Exercise
    Vitamin D placebo + Sham (equivalent to placebo) Exercise
  • Drug: Vitamin D + Exercise
    1000 IU per day of Vitamin D + Exercise
Study Arms  ICMJE
  • Experimental: C
    Intervention: Procedure: Vitamin D Placebo + Exercise
  • Experimental: B
    Intervention: Drug: Vitamin D + Sham Exercise
  • Experimental: A
    Intervention: Drug: Vitamin D + Exercise
  • Placebo Comparator: D
    Intervention: Procedure: Vitamin D Placebo + Sham Exercise
Publications *Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Terminated
Actual Enrollment  ICMJE
 (submitted: November 4, 2005)
64
Original Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE January 2008
Primary Completion DateNot Provided
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Elderly subjects with moderate frailty residing in assisted living facilities.

Exclusion Criteria:

  • Presence of progressive, unstable chronic disease; hyperparathyroidism, hypercalcemia.
Sex/Gender  ICMJE
Sexes Eligible for Study:All
Ages  ICMJE 75 Years and older   (Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT00249704
Other Study ID Numbers  ICMJE A9001116
Has Data Monitoring CommitteeNo
U.S. FDA-regulated ProductNot Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible PartyDirector, Clinical Trial Disclosure Group, Pfizer, Inc.
Study Sponsor  ICMJE Pfizer
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Study Director:Pfizer CT.gov Call CenterPfizer
PRS AccountPfizer
Verification DateJanuary 2009

ICMJE     Data element required by the

International Committee of Medical Journal Editors
and the
World Health Organization ICTRP

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now